1.Recent development status of TCM in Australia and its implications
International Journal of Traditional Chinese Medicine 2024;46(4):420-425
This study investigated the Australian healthcare system, TCM policies, and the current situation of TCM practitioners, TCM education and TCM academic groups in Australia. Based on analysis of TCM services data released by Australian Government Department of Health and Aged Care, Australian Bureau of Statistics and Australian Health Practitioner Regulation Agency, this article summarized the recent development of TCM in Australia and drew inspiration. Australia has established a relatively sound management mechanism for TCM, in which the overall development of TCM practitioners is good, and the activities of TCM education institutions and academic groups are promoting the localization of TCM in Australia. In order to further promote the overseas development of TCM, it is necessary to gradually form a standardized system for international education of TCM and apply it in other countries. The construction of Sino-foreign TCM hospitals should be explored to enhance the influence of TCM. To keep up with the time, it is necessary to take more communication effort on "Generation Z".
2.Telomerase regulation factor PinX1 inhibits proliferation and invasion of hepatoma cells
Ruixi LI ; Zhicheng YAO ; Zhiyong XIONG ; Boxuan ZHOU ; Jianliang XU ; Kunpeng HU ; Weiming FAN ; Hao LIANG ; Meihai DENG
Chinese Journal of Hepatic Surgery(Electronic Edition) 2018;7(2):147-151
Objective To explore the impact of telomerase regulation factor PinX1 to the proliferation and invasion ability of hepatoma cells. Methods Hepatoma cells PinX1-7721 (experimental group) with stable expression of PinX1 as well as control cell VECTOR-7721 (control group) were constructed. The expression of PinX1 mRNA was detected by RT-PCR. The proliferation ability and clonality of hepatoma cells were detected by CCK-8 method and plate clonality assay, and the invasion ability of hepatoma cells by Transwell assay. Comparison of the experiment data was conducted by t test. Results Expression level of PinX1 mRNA in experiment group was (13.9±2.0)×10-3, which was significantly higher than (1.1±0.2)×10-3in control group (t=10.98, P<0.05). A450of the cells on 1-7 d in experiment group was respectively 0.260±0.004, 0.340±0.008, 0.450±0.040, 0.500±0.020, 0.730±0.030, 1.350±0.040 and 1.640±0.050, which were significantly lower than 0.280±0.009, 0.410±0.007, 0.680±0.044, 0.730±0.029, 0.850±0.070, 1.700±0.020 and 2.080±0.280 in control group (t=-5.82, -12.99, -6.36, -5.96, -28.42,-18.98, -5.08; P<0.05). The plate clonality assay results showed that the clone formation quantity of cells in experiment group was 143±32, which was significantly lower than 305±25 in control group (t=-6.91, P<0.05).Transwell assay results showed that the quantity of trans-membrane cell in experiment group was 230±16, which was significantly lower than 650±30 in control group (t=-21.40, P<0.05). Conclusion PinX1 could inhibit the proliferation and invasion ability of hepatoma cells.
3.Expression of PLVAP gene in hepatocellular carcinoma tissues and its clinical significance
Zhiyong XIONG ; Zhicheng YAO ; Kunpeng HU ; Jiezong WU ; Ruixi LI ; Boxuan ZHOU ; Hao LIANG ; Meihai DENG
Chinese Journal of Hepatic Surgery(Electronic Edition) 2018;7(6):511-515
Objective To investigate expression of plasmalemmal vesicle-associated protein (PLVAP) in hepatocellular carcinoma (HCC) tissues and its relationship with clinicopathological features.Methods Tissue specimens were collected from 108 patients with HCC in the Third Affiliated Hospital of Sun Yat-sen University from January 2013 to December 2015.92 patients were male and 16 female,aged (48±5) years on average.The informed consents of all patients were obtained and the local ethical committee approval was received.The expression level of PLVAP was analyzed based on the data of HCC in public databases.The expression level of PLVAP mRNA in HCC and paracarcinoma tissues was detected by RT-PCR,and the relationship between the expression of PLVAP and clinicopathological characteristics of HCC was analyzed.The relationship between PLVAP and prognosis of HCC patients was investigated with the data from cancer genome atlas (TCGA) database.The expression levels of PLVAP mRNA between HCC tissues and para-carcinoma tissues were compared by Kruskal-Wallis rank-sum test.Correlation analysis was performed by Chi-square test.Survival analysis was conducted by Kaplan-Meier survival curve and Log-rank test.Results According to Human Protein Atlas and Oncomine databases,the expression level of PLVAP in HCC tissues was significantly higher than that in normal liver tissues.RT-PCR showed that the median expression level of PLVAP mRNA in HCC tissues was 0.172(0.004-0.607),significantly higher compared with 0.091(0.002-0.513) in para-carcinoma tissues (Z=6.839,P<0.05).The expression level of PLVAP in HCC patients was significantly correlated with TB,tumor size and microvascular invasion (x2=4.183,3.924,6.075;P<0.05).In PLVAP high expression group,the overall survival and tumor-free survival were 58.8(0.5-107.0) and 42.2(0.1-67.2) months,where no significant difference from 55.7(0.2-120.7) and 20.9(0.1-109.4) months in PLVAP low expression group (x2=0.054,0.065;P>0.05).Conclusions The expression level of PLVAP is significantly correlated with the development and progression of HCC,whereas it is probably not associated with the prognosis of HCC patients.

Result Analysis
Print
Save
E-mail